Vanguard Group’s Kindred Biosciences, Inc. KIN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-1,890,913
Closed -$17.3M 4573
2021
Q2
$17.3M Sell
1,890,913
-111,957
-6% -$1.03M ﹤0.01% 2921
2021
Q1
$9.95M Buy
2,002,870
+19,845
+1% +$98.6K ﹤0.01% 3148
2020
Q4
$8.55M Buy
1,983,025
+18,577
+0.9% +$80.1K ﹤0.01% 3072
2020
Q3
$8.43M Sell
1,964,448
-13,779
-0.7% -$59.1K ﹤0.01% 2871
2020
Q2
$8.88M Buy
1,978,227
+55,464
+3% +$249K ﹤0.01% 2837
2020
Q1
$7.69M Buy
1,922,763
+17,715
+0.9% +$70.9K ﹤0.01% 2740
2019
Q4
$16.2M Buy
1,905,048
+20,994
+1% +$178K ﹤0.01% 2631
2019
Q3
$12.9M Buy
1,884,054
+175,120
+10% +$1.2M ﹤0.01% 2697
2019
Q2
$14.2M Buy
1,708,934
+30,940
+2% +$258K ﹤0.01% 2674
2019
Q1
$15.4M Buy
1,677,994
+254,538
+18% +$2.33M ﹤0.01% 2622
2018
Q4
$15.6M Buy
1,423,456
+13,442
+1% +$147K ﹤0.01% 2556
2018
Q3
$19.7M Buy
1,410,014
+80,023
+6% +$1.12M ﹤0.01% 2585
2018
Q2
$14.2M Buy
1,329,991
+210,077
+19% +$2.24M ﹤0.01% 2729
2018
Q1
$9.69M Buy
1,119,914
+103,369
+10% +$894K ﹤0.01% 2839
2017
Q4
$9.61M Buy
1,016,545
+167,145
+20% +$1.58M ﹤0.01% 2839
2017
Q3
$6.67M Buy
849,400
+104,078
+14% +$817K ﹤0.01% 3003
2017
Q2
$6.41M Buy
745,322
+272,612
+58% +$2.34M ﹤0.01% 2993
2017
Q1
$3.33M Buy
472,710
+44,062
+10% +$311K ﹤0.01% 3211
2016
Q4
$1.82M Sell
428,648
-5,689
-1% -$24.2K ﹤0.01% 3389
2016
Q3
$2.16M Buy
434,337
+1,400
+0.3% +$6.96K ﹤0.01% 3358
2016
Q2
$1.53M Buy
432,937
+7,098
+2% +$25.1K ﹤0.01% 3468
2016
Q1
$1.47M Buy
425,839
+7,830
+2% +$27K ﹤0.01% 3482
2015
Q4
$1.42M Buy
418,009
+38,641
+10% +$131K ﹤0.01% 3516
2015
Q3
$1.97M Buy
379,368
+9,028
+2% +$47K ﹤0.01% 3382
2015
Q2
$2.53M Sell
370,340
-2,461
-0.7% -$16.8K ﹤0.01% 3322
2015
Q1
$2.66M Buy
372,801
+37,881
+11% +$270K ﹤0.01% 3287
2014
Q4
$2.5M Buy
334,920
+30,548
+10% +$228K ﹤0.01% 3200
2014
Q3
$2.82M Buy
304,372
+72,531
+31% +$671K ﹤0.01% 3122
2014
Q2
$4.32M Buy
231,841
+80,689
+53% +$1.5M ﹤0.01% 2911
2014
Q1
$2.8M Buy
+151,152
New +$2.8M ﹤0.01% 3070